Group AC Meningococcal Polysaccharide Vaccine of Hualan Biological Bacterin Co., Ltd Passing GMP

Group AC Meningococcal Polysaccharide Vaccine of Hualan Biological Bacterin Co., Ltd Passing GMP
On March 26, 2018, Hualan Biological Bacterin Co., Ltd received production licenses of Group AC Meningococcal Polysaccharide Vaccine issued by CFDA. On May 8, 2018, Hualan Biological Bacterin Co., Ltd got GMP Certificate issued by CFDA, the certificate number is HA20180019, the certification scope is Group AC Meningococcal Polysaccharide Vaccine, valid until April 27, 2023. Then the company is approved to produce and sell the vaccines offically.
                                         


id=141

评论

此博客中的热门博文

Hualan Genetic Recombinant Anti-CTLA-4 Human Monoclonal Antibody Injection (Ipilimumab) Starting Clinical Trial

What You Should Know About Flu Antiviral Drugs?

Summary of Hualan Bio’s IVIG, Human Immunoglobulin (pH4) for Intravenous Injection